2021-01-04,Aravive to Present at the H.C. Wainwright Virtual BioConnect Conference
2020-12-31,Aravive Announces Board Member Transition to Advisory Role
2020-12-07,Is ARAV A Good Stock To Buy Now?
2020-11-19,Aravive Announces Phase 3 Trial Design for AVB-500 in Platinum Resistant Ovarian Cancer
2020-11-16,Here's Why We're Not Too Worried About Aravive's (NASDAQ:ARAV) Cash Burn Situation
2020-11-16,Aravive to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
2020-11-10,"Aravive to Host Virtual Expert Event Focused on Ovarian and Renal Cancer on November 20, 2020"
2020-11-10,Aravive and 3D Medicines Announce Strategic Collaboration to Develop and Commercialize AVB-500 in Greater China
2020-11-05,Aravive Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
2020-09-17,Aravive Appoints Michael W. Rogers to Board of Directors
2020-09-15,"Aravive Appoints Reshma Rangwala, M.D., Ph.D., as Chief Medical Officer"
2020-09-08,Aravive to Participate in Upcoming Virtual Investor Conferences in September
2020-08-27,Aravive Strengthens Leadership Team with Appointment of Key Industry Veterans
2020-08-13,Wedbush: 3 Healthcare Stocks Under $10 With Massive Upside Ahead
2020-08-03,Aravive Reports Second Quarter 2020 Financial Results and Provides Recent Corporate Updates
2020-07-30,Aravive to Participate in Upcoming Virtual Investor Conferences in August
2020-07-23,Aravive Announces Successful Completion of Phase 1b Trial Evaluating AVB-500 in Platinum Resistant Ovarian Cancer
2020-07-03,"What Kind Of Investors Own Most Of Aravive, Inc. (NASDAQ:ARAV)?"
2020-07-01,"The Daily Biotech Pulse: T2 Biosystems Launches COVID-19 Test, Akero Aces Midstage NASH Study, Aravive Added to Russell Indexes"
2020-06-30,Aravive Added to the Russell 2000® and Russell 3000® Indexes
2020-06-24,Aravive (ARAV) Stock Moves -1.47%: What You Should Know
2020-06-17,Aravive (ARAV) Dips More Than Broader Markets: What You Should Know
2020-06-12,"Hedge Funds Are Dumping Aravive, Inc. (ARAV)"
2020-05-12,Aravive To Present at The 2020 RBC Capital Markets Global Healthcare Conference
2020-05-06,Aravive Reports First Quarter 2020 Financial Results and Provides Recent Corporate Updates
2020-05-06,Aravive (ARAV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
2020-05-05,Aravive (ARAV) Flat As Market Gains: What You Should Know
2020-04-30,Aravive and WuXi Biologics Form Strategic Collaboration to Develop Novel High-Affinity Bispecific Antibodies Targeting Cancer and Fibrosis Using the WuXiBody Platform
2020-04-27,Aravive (ARAV) Gains But Lags Market: What You Should Know
2020-04-27,"Is ARAVIVE, INC (ARAV) Outperforming Other Medical Stocks This Year?"
2020-04-22,"Aravive's Shares March Higher, Can It Continue?"
2020-04-20,Top Ranked Momentum Stocks to Buy for April 20th
2020-04-20,bluebird bio (BLUE) Catches Eye: Stock Jumps 6%
2020-04-16,Aravive (ARAV) in Focus: Stock Moves 8% Higher
2020-04-16,Outlook Therapeutics (OTLK) Catches Eye: Stock Jumps 7.6%
2020-04-15,"Aravive (ARAV): Strong Industry, Solid Earnings Estimate Revisions"
2020-04-09,Aravive Announces Board Composition and Executive Management Transitions
2020-03-30,Aravive Announces AVB-500 Improves Anti-Tumor Effects when Combined with Anti-Angiogenic Bevacizumab or PARP Inhibitor Olaparib in Preclinical Models of Uterine Cancer
2020-03-30,We're Not Very Worried About Aravive's (NASDAQ:ARAV) Cash Burn Rate
2020-03-27,"Aravive Reports Fourth Quarter and Twelve Months Ended December 31, 2019 Financial Results and Provides Recent Corporate Updates"
2020-03-24,Aravive Announces Initiation of Investigator-Sponsored Phase 1/2 Study of AVB-500 in Combination with Avelumab in Patients with Advanced Urothelial Carcinoma (COAXIN)
2020-02-25,Aravive To Present at The Cowen and Company 40th Annual Health Care Conference
2020-02-18,Aravive Announces Dose Escalation of AVB-500 in Recurrent Platinum Resistant Ovarian Cancer Phase 1b Trial
2020-01-13,Aravive Receives IND Clearance for Phase 1b/Phase 2 Clinical Trial of AVB-500 in Patients with Clear Cell Renal Cell Carcinoma
2020-01-10,"The Daily Biotech Pulse: Positive Data Readouts To Spur Aclaris, Moderna And Ultragenyx"
2020-01-09,Aravive Announces Management Changes
2020-01-02,3 Healthcare Stocks Primed for 2020 Gains
2019-12-23,"Is Aravive, Inc. (ARAV) A Good Stock To Buy?"
2019-12-20,Aravive Initiates a Phase 2a Clinical Trial of AVB-500 in Patients with Kidney Fibrosis
2019-12-02,Aravive Announces Participation at the 2019 Piper Jaffray Healthcare Conference
2019-11-29,Implied Volatility Surging for Aravive (ARAV) Stock Options
2019-11-27,Aravive Announces Pricing of Public Offering of Common Stock
2019-11-27,"The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen"
2019-11-26,Aravive Announces Proposed Public Offering of Common Stock
2019-11-20,Here's Why This Tiny Biotech Stock Briefly Doubled In Value Overnight
2019-11-20,Aravive shares jump on ovarian cancer data
2019-11-20,"Aravive Reports Positive Data Supporting Relationship Between AVB-500 Levels, Anti-Tumor Activity and Progression Free Survival in Women with Ovarian Cancer"
2019-11-12,Aravive and AstraZeneca Announce Initiation of Randomized Phase 1/2 Study of AVB-500 in Combination with Durvalumab in Patients with Platinum-Resistant Recurrent Epithelial Ovarian Cancer
2019-11-08,CORRECTION  Aravive Reports Third Quarter 2019 Financial Results and Provides Recent Corporate Updates
2019-11-07,Aravive Reports Third Quarter 2019 Financial Results and Provides Recent Corporate Updates
2019-11-03,"Does Aravive, Inc.'s (NASDAQ:ARAV) CEO Salary Compare Well With Others?"
2019-10-18,Aravive Announces Publication of AVB-500 Nonclinical Study in Treatment-Resistant ccRCC Animal Models in Cancer Research
2019-09-27,Aravive Presents Positive Data from Initial 12 Patients in Phase 1b Portion of its Phase 1b/2 Ovarian Cancer Study of AVB-500 in Late Breaking Oral Presentation at European Society for Medical Oncology Congress in Barcelona
2019-09-27,Aravive Announces Participation at the 2019 Cantor Global Healthcare Conference
2019-09-19,"Will Aravive, Inc. (NASDAQ:ARAV) Need To Raise More Money?"
2019-09-18,Aravive to Present Late-Breaking Oral Presentation at European Society for Medical Oncology Congress 2019 in Barcelona
2019-08-08,Aravive Announces Executive Management Transition Plan
2019-08-08,Aravive Announces Participation at Wedbush PacGrow Healthcare Conference
2019-08-07,"Aravive (ARAV) Reports Q2 Loss, Tops Revenue Estimates"
2019-08-07,Aravive Reports Second Quarter 2019 Financial Results and Provides Recent Corporate Updates
2019-07-31,"Introducing Aravive (NASDAQ:ARAV), The Stock That Collapsed 95%"
2019-07-31,Aravive Reports Preliminary Results of AVB-500 from the First Cohort of the Phase 1b/Phase 2 Recurrent Platinum Resistant Ovarian Cancer Trial
2019-07-08,Aravive Announces Independent Data Monitoring Committee Recommends Continuation of Phase Ib Study of AVB-500 In Recurrent Platinum Resistant Ovarian Cancer After Review of First Two Cohorts of Patients
2019-05-08,Aravive: 1Q Earnings Snapshot
2019-05-08,Aravive Reports First Quarter 2019 Financial Results and Provides Recent Corporate Updates
2019-04-25,"Do Insiders Own Shares In Aravive, Inc. (NASDAQ:ARAV)?"
2019-03-19,Aravive Announces Retrospective Analysis Showing Increased GAS6 Levels Associated with Chemoresistance and Decreased Progression Free Survival in Ovarian Cancer
2019-03-15,"Aravive Inc (ARAV) Files 10-K for the Fiscal Year Ended on December 31, 2018"
2019-03-11,"Heres What We Think About Aravive, Inc.s (NASDAQ:ARAV) CEO Pay"
2019-03-08,CORRECTING AND REPLACING - Aravive Announces Participation at Cowen and Company 39th Annual Health Care Conference
2019-03-07,Aravive Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Recent Corporate Updates
2019-03-05,Aravive Announces Participation at Cowen and Company 39th Annual Health Care Conference
2019-02-28,"Aravive to Report Fourth Quarter and Full Year 2018 Financial Results and Corporate Updates on March 7, 2019"
2019-02-19,Aravive Receives Additional $2.6 Million Disbursement from the Cancer Prevention and Research Institute of Texas
2019-02-14,"Aravive Expands Executive Team with Promotion of Gail McIntyre, PhD, DABT to Chief Scientific Officer"
2019-01-29,"Aravive to Host Key Opinion Leader Breakfast Symposium on AVB-S6-500 and the GAS6-AXL Pathway on February 5, 2019"
2018-12-11,Aravive Biologics Initiates Phase 1b Portion of Phase 1b/2 Clinical Trial of AVB-S6-500 in Platinum-Resistant Recurrent Ovarian Cancer
2018-11-26,Aravive Announces Participation at Upcoming Investor Conference
2018-11-13,Aravive Presents Detailed Results of Phase 1 Clinical Trial of AVB-S6-500 at the 2018 EORTC-NCI-AACR Symposium
2018-11-06,Versartis: 3Q Earnings Snapshot
2018-11-06,Aravive Reports Third Quarter 2018 Financial Results and Provides Company Updates
